LA
EW icon

Lee Ainslie’s Edwards Lifesciences EW Stock Holding History

Lee Ainslie’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,594
Closed -$1.95M – 249
2024
Q3 		$1.95M Buy
+29,594
New +$2.15M 0.04% 125
2024
Q1 		– Sell
-2,977
Closed -$227K – 455
2023
Q4 		$227K Sell
2,977
-2,331
-44% -$162K ﹤0.01% 323
2023
Q3 		$368K Buy
5,308
+990
+23% +$79.6K 0.01% 203
2023
Q2 		$407K Sell
4,318
-2,815
-39% -$245K 0.01% 280
2023
Q1 		$590K Buy
7,133
+3,511
+97% +$276K 0.01% 212
2022
Q4 		$270K Sell
3,622
-10,616
-75% -$818K 0.01% 313
2022
Q3 		$1.18M Buy
+14,238
New +$1.37M 0.03% 127
2020
Q4 		– Sell
-15,652
Closed -$1.25M – 710
2020
Q3 		$1.25M Sell
15,652
-14,889
-49% -$1.16M 0.02% 223
2020
Q2 		$2.11M Buy
+30,541
New +$2.17M 0.04% 169
2018
Q4 		– Sell
-117,480
Closed -$6.82M – 272
2018
Q3 		$6.82M Sell
117,480
-188,040
-62% -$9.2M 0.08% 130
2018
Q2 		$14.8M Buy
305,520
+81,090
+36% +$3.78M 0.17% 61
2018
Q1 		$10.4M Sell
224,430
-13,950
-6% -$606K 0.13% 93
2017
Q4 		$8.96M Buy
238,380
+100,710
+73% +$3.7M 0.11% 66
2017
Q3 		$5.02M Buy
137,670
+36,630
+36% +$1.4M 0.06% 76
2017
Q2 		$3.98M Buy
101,040
+8,370
+9% +$306K 0.05% 64
2017
Q1 		$2.91M Sell
92,670
-22,650
-20% -$709K 0.04% 49
2016
Q4 		$3.6M Buy
115,320
+34,620
+43% +$1.12M 0.05% 34
2016
Q3 		$3.24M Sell
80,700
-16,200
-17% -$610K 0.04% 48
2016
Q2 		$3.22M Buy
+96,900
New +$3.32M 0.04% 43
2015
Q3 		– Sell
-11,760
Closed -$279K – 123
2015
Q2 		$279K Hold
11,760
– – ﹤0.01% 64
2015
Q1 		$279K Buy
+11,760
New +$264K ﹤0.01% 67

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Lee Ainslie's EW Position: Q4 2024 in Review

Lee Ainslie sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 29,594 shares — an estimated $1.95M sold.

Lee Ainslie first reported a position in EW in Q1 2015 and held it in 21 quarters. The position peaked at $14.8M in Q2 2018. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Lee Ainslie reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Lee Ainslie sold 29,594 Edwards Lifesciences shares in Q4 2024, an estimated $1.95M.
  • Lee Ainslie first reported a position in Edwards Lifesciences in Q1 2015 and held it in 21 quarters.
  • Lee Ainslie's Edwards Lifesciences position peaked at $14.8M in Q2 2018.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Maverick Capital's 13F filing for Q4 2024, filed 14 Feb 2025.